Trial intelligence / Profile preview

TRANSLINK: Immune Events in Patients Receiving Animal-derived Bioprosthetic Heart Valves

NCT02023970Completed

Sponsor
CHU de Nantes
Start
Jan 2014
Primary completion
Jan 2018
Countries
4
01

Overview

Open-label trial (3 arms), sponsored by CHU de Nantes. Primary endpoint: Echocardiography data to assess the structural valve deterioration at 5 years. Started Jan 2014; status: completed.

Beyond the preview

Go deeper on NCT02023970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02023970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call